Dr. Holly J. Carveth, MD

Dr. Carveth practices at University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah.

Dr. Carveth's NPI, 1376633966, was assigned on October 13, 2006. Dr. Carveth holds Utah license 170333-1205.

Dr. Carveth's primary practice is University of Utah Hospitals and Clinics - Unit, at 50 North Medical Drive, Salt Lake City, UT 84132 in Salt Lake County. The practice phone is (801) 581-2337.

Dr. Carveth's primary practice is University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah. Dr. Carveth is also affiliated with University of Utah Hospital. The medical group on file is University of Utah Health. Dmand AI also links Dr. Carveth to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Carveth practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Carveth's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Carveth is licensed in Utah.

CMS data shows 484 Medicare services from Dr. Carveth across 8 procedure codes in 2024, for 109 Medicare patients. Medicare paid $34,947 for them.

CMS counts 109 Medicare patients who saw Dr. Carveth in 2024. The largest group is 65 to 74, with 46 patients. 74% of them have copd, and 65% have high blood pressure. 29% are also on Medicaid. Their average risk score is 2.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Carveth's median patient age at 61, with 53% women.

In 2024, Dr. Carveth wrote 1,340 Medicare Part D claims for 74 patients. CMS names the drug for 1,023 of them, across 37 drugs with 11 or more claims each, at $6,072,438 in total drug cost. In 2023, CMS named 876 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Carveth for performance year 2024, reported as part of a group. Dr. Carveth accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Carveth as offering telehealth.

Dmand AI links 3 papers to Dr. Carveth, published from 2012 to 2024. The most frequent topics are Cystic Fibrosis. Dr. Carveth's most frequent co-authors are Theodore Geh-Lu Liou, MD, Haley S. Belt, MD and Barbara C. Cahill, MD.

CMS Open Payments shows 3 general payments to Dr. Carveth from 1 drug or device company from 2016 to 2017. Food and beverage make up the largest share, 100% of the total. Respiratory Technologies, Inc. paid the most, $46.